Jeffrey Zekaukas
Stock Analyst at JP Morgan
(1.57)
# 3,381
Out of 4,974 analysts
26
Total ratings
40%
Success rate
-1.86%
Average return
Main Sectors:
Stocks Rated by Jeffrey Zekaukas
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MOS The Mosaic Company | Maintains: Overweight | $35 → $37 | $32.45 | +14.02% | 6 | Aug 11, 2025 | |
EMN Eastman Chemical Company | Downgrades: Neutral | $112 → $76 | $69.06 | +10.05% | 8 | Apr 28, 2025 | |
ECL Ecolab | Downgrades: Neutral | $200 → $220 | $273.56 | -19.58% | 5 | Feb 14, 2024 | |
LYB LyondellBasell Industries | Upgrades: Overweight | $95 → $100 | $55.08 | +81.55% | 3 | Feb 5, 2024 | |
AVY Avery Dennison | Maintains: Overweight | $185 → $218 | $168.06 | +29.72% | 2 | Feb 1, 2024 | |
LLY Eli Lilly and Company | Maintains: Equal-Weight | $148 → $157 | $727.21 | -78.41% | 2 | Aug 14, 2020 |
The Mosaic Company
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $37
Current: $32.45
Upside: +14.02%
Eastman Chemical Company
Apr 28, 2025
Downgrades: Neutral
Price Target: $112 → $76
Current: $69.06
Upside: +10.05%
Ecolab
Feb 14, 2024
Downgrades: Neutral
Price Target: $200 → $220
Current: $273.56
Upside: -19.58%
LyondellBasell Industries
Feb 5, 2024
Upgrades: Overweight
Price Target: $95 → $100
Current: $55.08
Upside: +81.55%
Avery Dennison
Feb 1, 2024
Maintains: Overweight
Price Target: $185 → $218
Current: $168.06
Upside: +29.72%
Eli Lilly and Company
Aug 14, 2020
Maintains: Equal-Weight
Price Target: $148 → $157
Current: $727.21
Upside: -78.41%